The Lin-gang Special Area in East China's Shanghai on July 27 started construction of an international pharmaceutical and health industrial park, at the southern part of Shanghai Pudong International Airport – a section of the Yangshan Free Trade Zone.

The park will cost Shanghai Pharmaceuticals Holding Co Ltd, or Shanghai Pharma, a modern provider of pharmaceutical supply chain services, 2 billion yuan ($300 million). It will be developed over three phases.

The aim is to offer supply chain platform lifecycle services and attract upstream pharma enterprises from all over the world to Lin-gang.

An artist's impression of the planned Lin-gang Special Area Pharmaceutical and Health International Industrial Park. [Photo/WeChat ID: shlgguanweihui]

Zhao Yihuai, deputy director of the Lin-gang Special Area Administration, said that the facility will move to form a logistics mode for drugs and medical devices that is integrated with urban areas and port areas.

That goal is based on the innovative approaches to regulations by Shanghai Customs, such as the non-sensorial regulation of the Yangshan Free Trade Zone – there is no sense of supervision normally, but once there is a violation, the problem will be immediately identified. As a result, the expectation is that the new complex will better serve the medical and pharma industries in Lin-gang, Shanghai and in the Yangtze River Delta regions.

Zhang Yi, deputy director of Shanghai Customs, pledged that it would fully facilitate customs clearances and boost its policy applications – as well as explore new innovative measures – to support the development of the pharmaceutical and health industrial park.